Rituximab bests fingolimod in MS patients switching from natalizumab

For patients with relapsing-remitting multiple sclerosis (RRMS) switching to other therapies due to positive JC virus serology, treatment with rituximab resulted in a lower rate of clinical relapse...
Source: Clinical Neurology News - Category: Neurology Source Type: news